
More than 300 million people worldwide are chronically infected with zzso B virus zzso and are at greatly increased risk of developing liver zzso and eventually primary liver zzso While infection can, with relative success, be prevented by zzso no generally effective therapy for chronic zzso B is zzso Hence there is an urgent need for novel zzso zzso Recent advances in our understanding of the mechanisms underlying virus replication and assembly provide opportunities for the rational design of molecules that could specifically interfere with these zzso some of these possibilities are discussed in this zzso 

